Will the FDA approve baxdrostat for hard-to-control hypertension?
Prediction market on kalshi. If the FDA approves baxdrostat for hard-to-control hypertension for marketing before Jan 1, 2027, then the market resolves to Yes.
Resolves: 1/8/2027.
Will the FDA approve baxdrostat for hard-to-control hyperten | Blockcircle